Target intelligence / Profile preview

RNA, U6 small nuclear 1135, pseudogene (RNU6-1135P)

Target
RNU6-1135P
Molecular classification
Pseudogene (processed pseudogene), Small nuclear RNA-derived sequence, Non-coding RNA fragment
01

Overview

RNU6-1135P is a processed pseudogene derived from the U6 small nuclear RNA gene, a pivotal non-coding RNA component of the spliceosome active in pre-mRNA splicing in eukaryotes[1][3]. Unlike functional U6 snRNA, pseudogenes such as RNU6-1135P result from retrotransposition events mediated by LINE-1 (L1) elements, and do not encode active RNA molecules or proteins nor participate in spliceosome assembly or cellular pathways[2][5]. Their sequences sometimes retain recognizable motifs or ends of U6 RNA but typically lack both intronic structure and functional secondary structure, often existing as nonfunctional genomic fragments[2][5]. These pseudogenes are prevalent in the vertebrate genome and are used by researchers to study retrotransposon activity and genome evolution, rather than serving as functional nucleic acids or drug targets[2][5][3]. If more information on functional U6 snRNA or other spliceosomal RNA targets is required, refer to research on U6 small nuclear RNA rather than its pseudogene variants, which have no direct biomedical utility[3][1].

Other names
RNU6-1135PRNA, U6 small nuclear 1135, pseudogeneU6 snRNA pseudogene
02

Mechanism of action

None (no mechanisms of drug action are applicable to this pseudogene)

03

Biological functions

None (no known biological function, as pseudogenes usually lack transcriptional or protein-coding activity)
04

Disease associations

Other (snRNA pseudogenes, including those of U6, mainly serve as markers of retrotransposition activity and do not have established disease roles)
05

Safety considerations

None (not a drug target, no safety concerns reported)
06

Interacting drugs

None (no drugs are known to interact specifically with RNA, U6 small nuclear pseudogenes)
07

Biomarkers

Other (occasionally used as genetic markers for retrotransposition dynamics, but not as biomarkers for patient selection or drug efficacy)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1135, pseudogene (RNU6-1135P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1135, pseudogene (RNU6-1135P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call